Kevin M. Brady
CIK 1877121 · View on SEC EDGAR ↗
First SEC filing: Aug. 10, 2021 · Latest: Aug. 10, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 31, 2023 | MEDP | S | 7,000 | $255.00 | $1,785,000 | 6,000 Direct | -53.85% | Disposed | 142.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 31, 2023 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (10,000) | $90.65 | Aug. 5, 2024 | 10,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 10, 2021 | MEDP | Common Stock | 5,000 | Direct |
| Aug. 10, 2021 | MEDP | Employee Stock Option (Right to Buy)→ Common Stock (12,000) | 12,000 | Direct |
| Aug. 10, 2021 | MEDP | Employee Stock Option (Right to Buy)→ Common Stock (11,250) | 11,250 | Direct |
| Aug. 10, 2021 | MEDP | Employee Stock Option (Right to Buy)→ Common Stock (3,000) | 3,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MEDP
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $459,695 | $172,450 | — | — | — | — | $14,000 | $1,646,197 |
| 2024 | $421,600 | $221,350 | — | — | — | — | $13,800 | $3,484,250 |
| 2023 | $399,500 | $279,731 | — | — | — | — | $11,250 | $690,481 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.